Скачать или смотреть AbbVie Unleashes Botox Bombshell $ABBV

AbbVie has announced a mid-stage trial success for Botox in treating essential tremors, sparking investor interest in the company's potential expansion of its biologic empire, and also made a biologic filing that has excited investors.
The company, however, has cut its earnings forecast due to a one-time charge from its research and development endeavors, leading to debate among shareholders about the move's strategic implications.

Discover what's trending in the stock market arena.

💎 Catalysts for trending stocks & coins
🍃 Social media & market sentiment
⌛ Real-time summary & technical analysis

stay on top of stocks and more with @trndgtr 📈

#shorts #discover #fyp #explore